US pharmacy pricing
Bimzelx Prices at US Pharmacies
Lowest price found · US pharmacies
$16,336.01/fill
for Bimzelx, across the pharmacies in our data
US pharmacy prices — 2ml of 320mg/2ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $16,336.01Lowest | $16,339.01 | $12,037.03 | |
| $16,336.01Lowest | $16,339.01 | $12,037.03 | |
| $17,139.43 | $17,142.43 | $12,037.03 | |
| $17,240.89 | $17,243.89 | $12,037.03 | |
| $17,638.72 | $17,641.72 | $12,037.03 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Bimzelx.
Frequently asked questions
Is Bimzelx (Bimzelx) expensive if I don't have insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Bimzelx is around $16,336.01. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Bimzelx available?
Generic and brand-name pricing for Bimzelx is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How does insurance affect the price of Bimzelx?
The cost of Bimzelx with insurance depends entirely on your specific plan's formulary and coverage rules. You should check with your insurer to confirm whether Bimzelx is covered and what your copay or coinsurance would be. If your plan does not cover this medication, you may still be able to use a pharmacy savings program to obtain a discounted price at participating pharmacies. Patients with Medicare or Medicaid can also explore these savings options if their government plan does not provide coverage. Additionally, individuals with insurance may contact the manufacturer to inquire about eligibility for a Bimzelx savings card program.
What is Bimzelx and how is it used?
Bimzelx (bimekizumab-bkzx) is an injectable prescription biologic medication approved to treat moderate-to-severe plaque psoriasis in adults. It is a monoclonal antibody, classified as an interleukin-17 antagonist, that works by modulating the immune system to reduce inflammation. It is administered via subcutaneous injection into areas like the thigh, stomach, or upper arm. The typical dosing schedule involves two injections (for a total of 320 mg) at weeks 0, 4, 8, 12, and 16, followed by maintenance dosing every 8 weeks thereafter. The first dose is usually given in a clinical setting, after which, with proper training, self-administration or administration by a caregiver at home may be possible. It is important to rotate injection sites and avoid areas with active psoriasis, bruises, or skin abnormalities.
What are the possible side effects associated with Bimzelx?
Common side effects of Bimzelx can include headache, oral cold sores, skin redness or bumps, fatigue, yeast infections, injection site reactions (pain, redness, swelling), and gastrointestinal issues like nausea or diarrhea. Serious risks require immediate medical attention. The medication can suppress the immune system, increasing susceptibility to infections, including serious ones like tuberculosis (TB). Patients are typically screened for TB before starting therapy. Other serious risks include liver injury and, in rare cases, new or worsening depression or suicidal thoughts. Patients should contact their healthcare provider promptly if they experience signs of infection (e.g., fever, chills), symptoms of liver problems (e.g., abdominal pain, jaundice), or any changes in mood or behavior. This is not a complete list, and patients should discuss all potential side effects with their doctor or pharmacist.